Hardiman Roy C.

Track

Insider profile

Hardiman Roy C.'s trades of Principia Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-09-22 2020-09-18
PlS Planned sale
70,440 +9.8%
307.03
US$1,683,530 		70,440 +9.8% 307.03 US$1,683,530
2020-06-15 2020-06-12
PlS Planned sale
45,326 +41.0%
43.03
US$4,489,688 		45,326 +41.0% 43.03 US$4,489,688
2020-06-15 2020-06-12
PlS Planned sale
37,435 -19.5%
27.63
US$2,502,110 		37,435 -19.5% 27.63 US$2,502,110
2020-06-15 2020-06-12
PlS Planned sale
1,595 -1.3%
59.90
US$95,541 		1,595 -1.3% 59.90 US$95,541
2020-03-17 2020-03-13
PlS Planned sale
100 -0.1%
51.04
US$5,104 		100 -0.1% 51.04 US$5,104
2020-03-17 2020-03-13
PlS Planned sale
1,181 -1.0%
49.46
US$58,408 		1,181 -1.0% 49.46 US$58,408
2020-03-17 2020-03-13
PlS Planned sale
3,719 -3.1%
48.21
US$179,304 		3,719 -3.1% 48.21 US$179,304